Evidence map›Paper›PMID 39819634›Full record

ArticleMicrobiome2025

Gut microbial dysbiosis, IgA, and Enterococcus in common variable immunodeficiency with immune dysregulation.

Roos-Marijn Berbers, Fernanda L Paganelli, Joris M van Montfrans, Pauline M Ellerbroek, Marco C Viveen, Malbert R C Rogers, Moniek Salomons, Jaap Schuurmans, Martine van Stigt Thans, Remi M M Vanmaris and 9 more

Abstract read
In one paragraph

Article in Microbiome, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Review
  6. Frontiers in microbiology · 2026
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors.

Roos-Marijn BerbersDepartment of Medical Microbiology, University Medical Center Utrecht and Utrecht University, Utrecht, the Netherlands.
Fernanda L PaganelliDepartment of Medical Microbiology, University Medical Center Utrecht and Utrecht University, Utrecht, the Netherlands.
Joris M van MontfransDepartment of Pediatric Immunology and Infectious Diseases, University Medical Center Utrecht and Utrecht University, Utrecht, the Netherlands.
Pauline M EllerbroekDepartment of Internal Medicine and Infectious Diseases, University Medical Center Utrecht and Utrecht University, Utrecht, the Netherlands.
Marco C ViveenDepartment of Medical Microbiology, University Medical Center Utrecht and Utrecht University, Utrecht, the Netherlands.
Malbert R C RogersDepartment of Medical Microbiology, University Medical Center Utrecht and Utrecht University, Utrecht, the Netherlands.
Moniek SalomonsDepartment of Medical Microbiology, University Medical Center Utrecht and Utrecht University, Utrecht, the Netherlands.
Jaap SchuurmansDepartment of Rheumatology and Clinical Immunology, University Medical Center Utrecht and Utrecht University, Utrecht, the Netherlands.
Martine van Stigt ThansDepartment of Rheumatology and Clinical Immunology, University Medical Center Utrecht and Utrecht University, Utrecht, the Netherlands.
Remi M M VanmarisDepartment of Medical Microbiology, University Medical Center Utrecht and Utrecht University, Utrecht, the Netherlands.
Lodewijk A A BrosensDepartment of Pathology, University Medical Center Utrecht and Utrecht University, Utrecht, the Netherlands.
Maria Marlot van der WalCenter for Translational Immunology, University Medical Center Utrecht and Utrecht University, Utrecht, the Netherlands.
Virgil A S H DalmDepartment of Internal Medicine, Division of Clinical Immunology, Erasmus MC University Medical Center, Rotterdam, the Netherlands.
P Martin van HagenDepartment of Internal Medicine, Division of Clinical Immunology, Erasmus MC University Medical Center, Rotterdam, the Netherlands.
Annick A J M van de VenDepartments of Internal Medicine and Allergology, Rheumatology and Clinical Immunology, University Medical Center Groningen, Groningen, the Netherlands.
Hae-Won UhDepartment of Data Science and Biostatistics, Julius Center, University Medical Center Utrecht and Utrecht University, Utrecht, the Netherlands.
Femke van WijkCenter for Translational Immunology, University Medical Center Utrecht and Utrecht University, Utrecht, the Netherlands.
Rob J L WillemsDepartment of Medical Microbiology, University Medical Center Utrecht and Utrecht University, Utrecht, the Netherlands.
Helen L LeavisDepartment of Rheumatology and Clinical Immunology, University Medical Center Utrecht and Utrecht University, Utrecht, the Netherlands. h.leavis@umcutrecht.nl.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundCommon variable immunodeficiency (CVID) is characterized by hypogammaglobulinemia and recurrent infections. Significant morbidity and mortality are caused by immune dysregulation complications (CVIDid), which affect around one-third of CVID patients and have a poorly understood etiology. Here, we investigate the hypothesis that gut microbial dysbiosis contributes to the inflammation underlying CVIDid.

resultsBacterial invasion of colonic crypts was observed in CVID (3/15) and X-linked agammaglobulinemia (XLA, 1/3), but not in healthy control (HC, 0/9) biopsies. Fecal gut microbiota was characterized using 16S rRNA-targeted amplicon sequencing. Increased bacterial load, decreased alpha diversity and distinct beta diversity were observed in CVIDid (n = 42) compared to HC (n = 48), and similar results were seen in CVID with IgA deficiency (n = 40) compared to HC. CVIDid and CVID-IgA showed enrichment of the genus Enterococcus, and in vitro studies confirmed the inflammatory potential of Enterococcus gallinarum and Enterococcus hirae in patient monocytes.

conclusionsThis study further supports the hypothesis that a dysregulated gut microbiota, with IgA deficiency as an important driving factor, contributes to systemic inflammation in primary antibody deficiency, and introduces enterococci as potential pathobionts in CVIDid. Video Abstract.

Indexed as

Common Variable ImmunodeficiencyDysbiosisEnterococcusGastrointestinal MicrobiomeImmunoglobulin AAdultAgammaglobulinemiaFecesFemaleGenetic Diseases, X-LinkedHumansMaleMiddle AgedRNA, Ribosomal, 16SYoung AdultImmunoglobulin ARNA, Ribosomal, 16SCommon variable immunodeficiency (CVID)Gut microbiotaImmune dysregulationPathobionts

Identifiers

PMID39819634
PMCPMC11740714

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.